Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus brevis SBC8803 and Improved Immune Function

Research synthesisVery low evidenceSmall effect3 studies · 3 beneficial · 0 neutral · 0 harmful

Across 3 review-level studies, all reported small beneficial effects of Lactobacillus brevis SBC8803 on immune function, specifically enhanced natural killer cell activity and increased secretory IgA levels. However, none of the findings were statistically significant, and the evidence base is limited to narrative reviews rather than original clinical trials.

  • Studied populations: patients with psoriasis

Caveats: All studies are narrative reviews with no original data, no dose information, and no statistical significance reported. Only one study specified a population (psoriasis patients). Effect direction is consistent but based on very low-quality evidence.

Generated May 11, 2026
3 of 3 papers
Back to top